JANUS HENDERSON GROUP PLC - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 144 filers reported holding IMMUNITYBIO INC in Q4 2022. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
JANUS HENDERSON GROUP PLC ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q3 2023$101,374
-39.6%
60,516
+0.1%
0.00%
Q2 2023$167,841
+53.3%
60,482
+0.3%
0.00%
Q1 2023$109,493
-31.5%
60,325
+90.8%
0.00%
Q4 2022$159,857
+1.7%
31,622
-50.0%
0.00%
Q3 2022$157,157
+25.7%
63,244
+89.0%
0.00%
Q2 2022$125,00033,4700.00%
Other shareholders
IMMUNITYBIO INC shareholders Q4 2022
NameSharesValueWeighting ↓
Winning Points Advisors, LLC 236,956$879,0000.97%
HARBOURVEST PARTNERS LLC 335,709$1,249,0000.41%
ALLEN HOLDING INC /NY 687,571$2,558,0000.37%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$359,0000.15%
SHEETS SMITH WEALTH MANAGEMENT 207,926$773,0000.13%
Corton Capital Inc. 29,032$108,0000.10%
Clearwater Capital Advisors, LLC 185,311$689,0000.09%
Delphia (USA) Inc. 31,709$118,0000.08%
Virtus ETF Advisers LLC 34,799$129,0000.05%
GSA CAPITAL PARTNERS LLP 84,884$316,0000.05%
View complete list of IMMUNITYBIO INC shareholders